These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 16399845

  • 1. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
    Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.
    Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
    [Abstract] [Full Text] [Related]

  • 2. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC, Tervaert JW, Boomsma MM, Stegeman CA.
    Arthritis Rheum; 2004 Apr 15; 51(2):269-73. PubMed ID: 15077271
    [Abstract] [Full Text] [Related]

  • 3. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients.
    Arranz O, Ara J, Rodriguez R, Quintó L, Font J, Mirapeix E, Darnell A.
    Clin Nephrol; 2001 Oct 15; 56(4):295-301. PubMed ID: 11680659
    [Abstract] [Full Text] [Related]

  • 4. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
    Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F, van Paassen P, Stöcker W, Schlumberger W, Tervaert JW.
    Ann Rheum Dis; 2009 Feb 15; 68(2):228-33. PubMed ID: 18375539
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis.
    Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M, Grypiotis P, Todesco S.
    J Rheumatol; 2002 May 15; 29(5):918-23. PubMed ID: 12022350
    [Abstract] [Full Text] [Related]

  • 6. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
    Ara J, Mirapeix E, Rodríguez R, Pascual J, Alvarez L, Darnell A.
    Med Clin (Barc); 1998 Oct 31; 111(14):536-8. PubMed ID: 9859079
    [Abstract] [Full Text] [Related]

  • 7. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.
    Nephrol Dial Transplant; 2004 Jun 31; 19(6):1403-11. PubMed ID: 15069175
    [Abstract] [Full Text] [Related]

  • 8. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
    Holle JU, Hellmich B, Backes M, Gross WL, Csernok E.
    Ann Rheum Dis; 2005 Dec 31; 64(12):1773-9. PubMed ID: 15843447
    [Abstract] [Full Text] [Related]

  • 9. Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis.
    Rarok AA, Huitema MG, van der Leij MJ, van der Geld YM, Berthold H, Schmitt J, Stegeman CA, Limburg PC, Kallenberg CG.
    Am J Clin Pathol; 2003 Oct 31; 120(4):586-95. PubMed ID: 14560570
    [Abstract] [Full Text] [Related]

  • 10. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
    Vizjak A, Rott T, Koselj-Kajtna M, Rozman B, Kaplan-Pavlovcic S, Ferluga D.
    Am J Kidney Dis; 2003 Mar 31; 41(3):539-49. PubMed ID: 12612976
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
    Csernok E, Holle J, Hellmich B, Willem J, Tervaert C, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL.
    Rheumatology (Oxford); 2004 Feb 31; 43(2):174-80. PubMed ID: 14585921
    [Abstract] [Full Text] [Related]

  • 12. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
    Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CG, Limburg PC, Tervaert JW.
    Arthritis Rheum; 2000 Sep 31; 43(9):2025-33. PubMed ID: 11014352
    [Abstract] [Full Text] [Related]

  • 13. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA.
    Nephrol Dial Transplant; 2016 Sep 31; 31(9):1453-9. PubMed ID: 27242368
    [Abstract] [Full Text] [Related]

  • 14. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA, Fass DN, Specks U.
    Arthritis Rheum; 2001 Feb 31; 44(2):463-8. PubMed ID: 11229478
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
    Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman CA, Van Paassen P, Tervaert JW.
    Ann N Y Acad Sci; 2007 Aug 31; 1109():454-63. PubMed ID: 17785334
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse.
    Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.
    Ann Rheum Dis; 2006 Nov 31; 65(11):1484-9. PubMed ID: 16504995
    [Abstract] [Full Text] [Related]

  • 17. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies.
    Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA.
    Arthritis Rheum; 2000 Jan 31; 43(1):226-31. PubMed ID: 10643719
    [Abstract] [Full Text] [Related]

  • 18. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O, Ara J, Rodríguez R, Poveda R, Serra A, Solé-Amigó J, Fort J, Mirapeix E, Darnell A.
    Nefrologia; 2001 Jan 31; 21(4):349-54. PubMed ID: 11816510
    [Abstract] [Full Text] [Related]

  • 19. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
    Hermann J, Demel U, Stünzner D, Daghofer E, Tilz G, Graninger W.
    Ann Rheum Dis; 2005 Apr 31; 64(4):641-3. PubMed ID: 15485998
    [Abstract] [Full Text] [Related]

  • 20. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
    Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Specks U.
    J Immunol Methods; 2005 Dec 20; 307(1-2):62-72. PubMed ID: 16242707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.